Table 6
|  | n = 58 |
|---|---|
Ever smoked, n (%) | 29 (53) |
 Pack years | 1 (0; 25) |
Medication data | |
 Erythropoietin (units/week) | 6000 (1000; 9000) |
 Intravenous iron (mg/week) | 0.0 (0.0–50.0) |
 ACE inhibitors, n (%) | 5 (8.6) |
 ARB, n (%) | 7 (12.1) |
 Beta-blockers, n (%) | 26 (44.8) |
 Statins, n (%) | 35 (60.3) |
 Calcium-channel blockers, n (%) | 27 (46.6) |
 Diuretics, n (%) | 17 (29.3) |
 Alpha blockers, n (%) | 11 (19.0) |
 Aspirin, n (%) | 24 (41.4) |
 Insulin, n (%) | 14 (24.1) |
 Oral hypoglycaemic, n (%) | 6 (1.0) |
Haematological and biochemical data | |
 Sodium (mmol/L) | 136.6 ± 3.2 |
 Potassium (mmol/L) | 5.0 ± 0.9 |
 Bicarbonate (mmol(L) | 25.3 ± 3.0 |
 Phosphate (mmol/L) | 1.5 (1.3; 2.0) |
 Calcium (mmol/L) | 2.3 ± 0.2 |
 Urea reduction ratio (%) | 76.5 (70.8; 81.3) |
 Haemoglobin (g/L) | 111.5 (99.0; 123.0) |
 Total cholesterol (mmol/L) [n = 45] | 3.8 (3.0; 4.5) |
 HbA1c (%) [n = 43] | 5.8 (5.1; 7.2) |
 WCC (109/L) | 6.3 (5.3; 8.8) |
 Platelets (109/L) | 215.3 ± 82.8 |
 Albumin (g/L) | 36.8 ± 5.2 |
 Ferritin (ng/ml) [n = 57] | 278 (176; 403) |
 CRP detectable (≥5) [n = 45] | 22 |
 CRP (mg/L) [n = 22] | 18 (12; 36) |
 PTH [n = 37] | 49 (17; 82) |